Priyanka Mahapatra

New Capabilities

Advocated for expanding CGM access to non-insulin patients at high cardiovascular risk

For millions of Americans with type 2 diabetes who don't take insulin, checking blood sugar has meant fingerstick tests a few times a day. A 26-week trial published in the New England Journal of Medicine in October showed that continuous glucose monitors (CGMs), small sensors worn on the arm that stream glucose readings, kept patients in a healthy blood sugar range for about five extra hours each day.

Updated Oct 18